The largest database of trusted experimental protocols

Human hepacam protein extracellular domain ecd

Manufactured by Sino Biological

The Human HepaCAM protein extracellular domain (ECD) is a recombinant protein product. HepaCAM is a cell adhesion molecule that plays a role in cell-cell interactions. The extracellular domain of the protein is produced using a recombinant expression system.

Automatically generated - may contain errors

2 protocols using human hepacam protein extracellular domain ecd

1

Neuronal Exosome Internalization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dynasore (Sigma-Aldrich), RNase A (Roche), Proteinase K (Fisher Scientific), CM-DiI (Thermo Fisher Scientific, C7001), and human HepaCAM protein extracellular domain (ECD, amino acid sequence 1-240, 16047-H08H) (Sino Biological Inc.) were used in this study. Dynasore (stock 50 mM) was prepared in DMSO and diluted 1000x in neuronal growth medium for treatment. Antibodies (final concentration 100 μg/ml) were mixed with neuronal growth medium and added onto primary neuronal cultures 2 h before A-Exo. treatment with exosomes. HepaCAM ECD coating is described below. Neuronal treatment with various drugs and/or exosomes was generally at DIV 3–4 for 24 h unless specifically described in main text.
+ Open protocol
+ Expand
2

Neuronal Exosomes Internalization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dynasore (Sigma Aldrich), RNase A (Roche), Proteinase K (Fisher Scientific), CM-DiI (Thermo Fisher Scientific, C7001), and human HepaCAM protein extracellular domain (ECD, amino acid sequence 1–240, 16047-H08H) (Sino Biological Inc.) were used in this study. Dynasore (stock 50 mM) was prepared in DMSO and diluted 1000x in neuronal growth medium for treatment. Antibodies (final concentration 100 μg/mL) were mixed with neuronal growth medium and added onto primary neuronal cultures 2 hours before A-Exo. treatment with exosomes. HepaCAM ECD coating is described below. Neuronal treatment with various drugs and/or exosomes was generally at DIV 3–4 for 24h unless specifically described in main text.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!